Skip to main content

Table 6 Adjusted annual medical costsa per patient by types of renal replacement therapies (CNY, 95%CI)

From: Direct medical costs of end-stage kidney disease and renal replacement therapy: a cohort study in Guangzhou City, southern China

 Overall HDOverall PDKT (first year)KT (second year)
No. Patients3765123711741
Total annual medical costs (CNY)94,760.5(85,166.6–106,972.2)80,762.9(76,249.8–85,498.9)132,253.0(114,009.9–153,858.6)93,155.3(61,120.6–101,989.1)
 Laboratory and diagnostic costs (CNY)724.7(257.2–1500.2)309.1(195.7–481.8)2325.4(2017.4–3260.2)/
 Non-medication treatment costs (CNY)73,801.2(69,423.2–79,717.3)10,390.0(8323.3–13,617.0)36,404.8(33,090.6–48,643.0)6013.0(5194.4–7458.4)
 Medication costs (CNY)19,527.1(14,657.2–26,696.9)69,654.7(63,253.9–76,369.8)89,598.9(69,504.8–106,162.1)86,958.0(53,530.9–95,595.2)
 Bed fees (CNY)350.1(133.9–743.3)266.4(177.1–407.8)2226.3(1648.0–4363.7)/
 Other fees (CNY)356.3(157.6–668.3)151.0(85.8–252.1)1698.6(1575.1–2179.4)3.1(0.6–9.2)
Out-of-pocket spending (CNY)12,302.0(9820.6–15,682.1)11,508.3(7759.0–14,559.9)31,281.3(24,042.6–36,188.1)15,670.5(10,387.4–19,025.4)
  1. HD Haemodialysis, PD Peritoneal Dialysis, KT Kidney Transplantation
  2. aAdjusted for age, gender, insurance types and three comorbidities (hypertension, diabetes, coronary) status using the generalized linear models;
  3. CNY, Chinese Yuan; CI, Confidence Interval
\